© Reuters. Is AmerisourceBergen a Buy or a Sell?
Fortune 500 company AmerisourceBergen (NYSE:) is the second largest drug distributor in the U.S. But will ABC be able to meet market demand for its products after closing its PharmaMEDium business? Read more to find out.AmerisourceBergen Corporation (ABC) is the second largest pharmaceutical drug distributor in the United States, and is currently ranked #8 in the Fortune 500 list and #23 in the Global 500 list. The company plays a vital role in the U.S. healthcare system.
ABC generated decent growth in its last reported quarter. Its shares of ABC have gained 17.1% year-to-date, and 16.2% over the past nine months.
And given the relatively inelastic demand for prescription drugs, ABC is expected to witness stable growth in its financials. In fact, we think the company’s latest strategic acquisitions should streamline its operations significantly, thereby strengthening its market reach.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.